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ABSTRACT
Given the inherent limitations of in silico studies
relying solely on DNA sequence analysis, the func-
tional characterization of mammalian promoters
and associated cis-regulatory elements requires ex-
perimental support, which demands cloning and
analysis of putative promoter regions. Focusing on
human chromosome 21, we cloned 182 gene pro-
moters of 2500bp in length and conducted
reporter gene assays on transfected-cell arrays.
We found 56 promoters that were active in HEK293
cells, while another 49 promoters could be activated
by treatment of cells with Trichostatin A or depletion
of serum. We observed high correlations between
promoter activities and endogenous transcript
levels, RNA polymerase II occupancy, CpG islands
and core promoter elements. Truncation of a subset
of 62 promoters to  500bp revealed that truncation
rarely resulted in loss of activity, but rather in loss of
responses to external stimuli, suggesting the
presence of cis-regulatory response elements
within distal promoter regions. In these regions,
we found a strong enrichment of transcription
factor binding sites that could potentially activate
gene expression in the presence of stimuli. This
study illustrates the modular functional architecture
of chromosome 21 promoters and helps to reveal
the complex mechanisms governing transcriptional
regulation.
INTRODUCTION
Gene expression in eukaryotic organisms requires
coordinated regulation of thousands of genes. The chal-
lenge is to unravel the components and function of
complex genetic networks and underlying regulatory
processes. Although these processes are integrated at
many diﬀerent levels of the cellular machinery, the regu-
lation of the initiation of transcription is essential and
often the rate-limiting step (1) and involves mainly
promoter regions located immediately upstream of the
gene transcription start sites (TSSs). These regions can
integrate various signals to control the transcription
rates of associated genes, such as spatial and temporal
cues during development, or in response to hormonal,
physiological and environmental signals (2). Promoter
regions usually entail a core promoter within 50–100bp
surrounding the TSS (3), proximal response elements
located up to 250bp upstream of the TSS, and distal
response elements, which can reside several kilobases
upstream and downstream of the TSS. The core
promoter contains transcription factor binding sites
(TFBSs) recognized by the general transcription factors
and regulates basal transcription levels, whereas
proximal and distal promoter regions are believed to
harbor gene-speciﬁc TFBSs integrating additional signals
for ﬁne-tuning of transcription rates (4).
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mainly on a gene-by-gene basis using various reporter
gene assays. Attempts to map promoter elements by
genome-wide computational analyses of the DNA
sequence made use of TFBS predictions and evolutionary
conservation of short DNA stretches (5), but these
approaches have been limited by the heterogenous
nature of promoter regions, and to some extent by the
sequence divergence of regulatory regions among
mammals (2). Large-scale experiments addressing the
architecture and activity of predicted promoters remain
essential. Of the few studies available so far, transient
reporter assays testing several hundred putative human
promoters detected activity for 60–68% of those in the
given experimental conditions (6,7). In a study by the
ENCODE consortium, 25% of putative promoters pre-
dicted de novo from cDNA analysis were reported to be
functional (6). These and other studies converge in
postulating that mammalian upstream regulatory regions
represent a heterogeneous group of modular elements with
disparate structural features and cell-type speciﬁc
activities (2,7,8). Additional systematic experimental
analyses are necessary to gain broader insight into
promoter structure and function.
We recently established a procedure based on
transfected-cell arrays for the functional characterization
of promoters (9). Here, we expanded this approach to
characterize the promoters of the human chromosome
21 (HSA21) genes, since HSA21 serves as a model for
pilot genomic studies due to its small size (48Mb) and
because of its association with Down syndrome. Based
on the 231 well-annotated protein-coding genes on
HSA21, we cloned 182 promoter fragments of 2.5kb in
size upstream of the predicted TSS, including the TSS
itself, as well as a set of shorter fragments (500bp
upstream of the TSS) for 62 promoters. We used
transfected-cell arrays (9–15) to carry out promoter
reporter assays in HEK293 cells under normal growth
conditions and after treatments known to alter gene ex-
pression. We correlated the measured activities with the
presence of core promoter elements, RNA polymerase II
occupancy (16), endogenous transcript levels, and expres-
sion proﬁles derived from EST data for 45 diﬀerent
human tissues. We show that data collected after treat-
ment of cells with diﬀerent stimuli can provide insight
into the presence and identity of functional cis-regulatory
elements. Taken together, we generated the ﬁrst
chromosome-scale reference data set on the structure,
function and responses of human gene promoters.
MATERIALS AND METHODS
Promoter annotation, primer design and
vector construction
Promoter annotation and primer design was based on
human gene annotations from the Ensembl database
v30. Promoter regions were deﬁned relative to the most
50 TSS of all annotated transcripts of a gene. PCR primers
for all 231 genes of chromosome 21 were designed using
the software PRIDE (17). The optimal target region for
the design was deﬁned as ranging from  2450 to+50bp
relative to the respective TSS. Each primer pair was
required to ﬂank the TSS. The downstream part was
shortened if an ATG appeared within the +50bp down-
stream region. In total, 223 primer pairs were obtained, to
which 12 bases of adapter sequences were added for re-
combination cloning after two-step PCR ampliﬁcation of
the fragments (Gateway technology, Invitrogen). The
same approach was used for cloning of truncated
promoter fragments of  500bp upstream of the TSS.
Promoter cloning
Touch-down PCR from genomic DNA was performed
according to a protocol optimized for ampliﬁcation of
GC-rich promoter regions (18), using as templates
genomic DNA as well as available genomic BAC and
fosmid clones. Then, a secondary PCR was performed
with Gateway adapter primers (Invitrogen), followed by
PEG-8000 precipitation of PCR products. The modiﬁed
reporter gene vector pZsGreen1-1 and the control plasmid
pHcRed1-N1 were used as described before (9). PCR
products were cloned into the pZsGreen vector using
Gateway BP Clonase II Enzyme Mix (Invitrogen) and
transformed into competent TOP10 cells following the
manufacturer’s recommendations. Resulting colonies
were screened by colony PCR, plasmids were isolated
from positive clones using a QIAprep Spin Miniprep Kit
(Qiagen), and inserts were conﬁrmed by 50 and 30 end
sequencing. Promoter coordinates and primer sequences
for 182 cloned promoter fragments are listed in
Supplementary Table S1.
Microarray spotting, cell culture and reverse transfection
Samples for array spotting were prepared as previously
described (9). Eﬀectene reagent (Qiagen) with Enhancer
(Qiagen) was used as transfection agent. Spotting solu-
tions containing 32ng/ml of promoter construct and
7.5ng/ml of reference plasmid were kept at 4 C until
arraying. Automated spotting was performed with a
high-speed non-contact dispensing system
(instrumentONE, M2 Automation). Arrays were printed
onto home-made poly-L-lysine (Sigma) coated microscope
glass slides using a 500mm outlet port solenoid valve,
which delivered 20nl of sample per spot. Average spot
to spot center distance was 1.5mm. Samples were
arrayed in triplicates. After arraying, slides were main-
tained in low humidity condition at 4 C. Human embry-
onic kidney cells (HEK293T from ATCC) were cultured in
Dulbecco’s modiﬁed Eagle’s medium (DMEM, Gibco
Invitrogen) supplemented with 10% (v/v) fetal calf
serum (Biochrom) at 37 C in a humidiﬁed 6% CO2 incu-
bator. One day prior to transfection, cells were seeded in a
60cm
2 culture plate in 10ml of medium. On the day of
transfection, cells were washed with PBS, detached with
Accutase (PAA Laboratories) and seeded at 3.5 10
6 per
slide onto printed slides, which were placed into a
QuadriPerm chamber (Greiner) for reverse transfection.
For each treatment, two slides were used in parallel, so
that for each construct, six replicate spots could be
analyzed. For treatments after 24h of incubation at 37 C
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calf serum, the medium was changed to DMEM/FCS
with 200nM Trichostatin A (Sigma) or fetal calf
serum-free DMEM. After 48h of transfection, slides
were washed with PBS, ﬁxed in 3.7% formaldehyde with
4M sucrose in PBS for 30min, stained with DAPI and
mounted with Fluoromount-G (Southern Biotech). The
slides were kept in the dark at 4 C until analysis.
Image acquisition, object detection and scoring of
promoter activity
Microscopy images were acquired and ﬂuorescent objects
were detected as previously described (9). The average
total number of cells per image frame was 649 cells, as
controlled by DAPI staining. In this area, the maximum
number of cells that could theoretically be transfected, i.e.
cells found in the area of the spotted DNA, was measured
to be 370 cells. For each scanning position, the number of
HcRed-expressing cells, ZsGreen-expressing cells and
co-transfected cells (HcRed- and ZsGreen-positive) was
determined. The average transfection eﬃciency for
HcRed alone was 14.1%, while an average of 7.8% of
the cells expressed ZsGreen, depending on promoter
reporter activity. The average total number of transfected
cells (positive for either ﬂuorophore) was 68 cells, resulting
in 18.4% combined average transfection eﬃciency. To de-
termine promoter reporter activities from numbers of
ﬂuorescent cells, two selection criteria were taken into
account. First, the fraction of green-ﬂuorescent cells
among all red cells in a spot had to exceed 16% (transfec-
tion threshold). Second, the number of cells both green
and red had to exceed the number of cells both green
and red in the negative control spots (empty
pZsGreen1-1 spotted in 10 replicates) by three standard
deviations (reporter activity threshold). A promoter was
classiﬁed as active if both thresholds were exceeded in at
least four out of six replicates on two diﬀerent cell array
slides. Thus, a binary promoter activity index (with 0 for
inactive and 1 for active promoters) was generated for
each promoter region under investigation.
Computational analyses
We used known position-weight matrices for TATA box,
INR and DPE elements (19) together with the TransFac
MATCH tool (20) for detection of common promoter
motifs under default parameters. Genome-wide coordin-
ates of CpG islands (21) were intersected with the coord-
inates of cloned promoters to identify CpG islands. In
this, we required 500bp immediately upstream of the
TSS to overlap with at least 10% of the total sequence
of a CpG island. Genome-wide coordinates of RNA poly-
merase IIA-bound regions in HEK293 (16) were inter-
sected with the coordinates of cloned promoters to
assess occupancy of the hypophosphorylated form of Pol
IIA in promoter regions.
We retrieved associations of expressed sequence tag
(EST) identiﬁers to UniGene cluster identiﬁers in 45
tissues generated for 5799931 human ESTs clustered
into 116190 UniGene clusters from the UniGene FTP
site (Hs.proﬁles.gz for Homo sapiens build #207). EST
expression proﬁles for these UniGene clusters were ex-
tracted from the ‘Body Sites’ category of the original
ﬁle. The resulting EST set for 156 HSA21 genes consisted
of 32450 ESTs from 45 tissues. We then calculated for
each gene with corresponding cloned promoter the
number of diﬀerent tissues where corresponding ESTs
could be found.
For the set of promoter sequences that showed speciﬁc
response patterns in our experiments, we searched for
common TFBSs that might explain these responses. To
score transcription factor binding, we used a physical
aﬃnity-based model described in previous publications
(22,23), and matrices describing 610 vertebrate transcrip-
tion factor binding preferences from TRANSFAC version
12.1 (20). For each binding matrix, we calculated the
aﬃnity of the matrix for each sequence, and then trans-
formed these aﬃnities into P-values as described before
(22). These P-values represent the probability that the
observed binding aﬃnity is greater than would be
expected from a random sequence from a
human-promoter-based background model. The P-values
for each sequence can then be combined using Fisher’s
method. P-values are not multiple test-corrected, and are
merely used to rank the factors. Each binding matrix is
then ranked according to its combined P-value, giving a
natural ranking of the transcription factors that have the
most enriched binding within the sequence set as a whole.
Enriched gene ontology (GO) terms were identiﬁed
using the DAVID functional annotation tool (24).
Entrez GeneIDs for 40 promoters activated by serum de-
pletion and 28 promoters activated by Trichostatin A were
compared to a background set of 126 inactive promoters
within the GO category ‘biological process’.
RESULTS
Cloning and reporter activity of HSA21 gene promoters in
HEK293 cells
Promoter fragments were selected for 231 genes on
HSA21, based on their most upstream annotated TSS
(see ‘Materials and methods’ section). Primer pairs encom-
passing 2.5kb of DNA sequence upstream of the TSS
could be designed for 223 promoter fragments. Of these,
182 fragments were successfully ampliﬁed and cloned into
a reporter vector upstream of the ZsGreen ﬂuorescent
reporter gene. Promoter coordinates, primer sequences
and supporting data for each TSS from RNA-seq and
Pol IIA ChIP-seq data (16) as well as CAGE and EST/
cDNA data (25,26) are listed in Supplementary Table S1.
Retrospective comparison with endogenous TSS coordin-
ates determined by RNA-seq from HEK293 indicated that
the use of Ensembl TSS annotations yielded slightly more
correct TSS positions than the use of predominant TSSs
derived from CAGE/EST data from other tissues or cell
types. Screenshots from the UCSC genome browser
showing all data sets for genes with contradictory TSS
data can be found in Supplementary Figure S2.
HEK293 cells were co-transfected on cell arrays spotted
with promoter reporter constructs and a normalization
plasmid expressing red ﬂuorescent protein HcRed. The
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be 18.4% (see ‘Materials and methods’ section). For as-
sessing reporter gene activity, we measured the ZsGreen
and HcRed ﬂuorescence signals in a cell-number-based
quantiﬁcation approach with stringent thresholds
ensuring a reliable readout (see ‘Materials and methods’
section and Supplementary Table S1). The mean numbers
of co-transfected cells were 32.9±5.9 and 6.2±4.8 for
promoter fragments scored as active and inactive, respect-
ively, whereas we found 1.7±2.0 transfected cells in the
negative controls. Figure 1A shows that this scoring
scheme allowed a clear-cut distinction to be made
between the active cloned promoter fragments (56 out of
182 tested) and the silent fragments (126 out of 182).
Promoter reporter activities correlate with endogenous
gene expression
We compared the capacity of the cloned promoters to
drive the transcription of a reporter gene with the en-
dogenous transcript levels previously determined for
HEK293 cells by RNA-seq (16). For the 56 active pro-
moters, 50 corresponding genes were found expressed
(Figure 1B), indicating a rate of 89% true positives in
the assay (Supplementary Table S1). In contrast, only 37
of 126 inactive promoters were associated with expressed
genes. The enrichment of expressed genes in the set of
active promoters was highly signiﬁcant (P=1.2 10
 14).
In order to distinguish promoters of ubiquitously ex-
pressed genes from those which might confer tissue speci-
ﬁcity, we made use of expression data compiled in
UniGene EST clusters (27). We observed a strong correl-
ation between promoter reporter activity in HEK293 cells
and the number of diﬀerent tissues in which the associated
genes were transcribed (Figure 1C). Out of 56, 38 active
promoters were associated with broadly expressed genes
(ESTs found in >25 diﬀerent tissues). In contrast, only 29
of the 126 inactive promoters controlled genes with a
broad expression pattern (Supplementary Table S1). The
enrichment of broadly expressed genes among active pro-
moters was highly signiﬁcant (P=1.1 10
 8).
For all genes analyzed, we correlated promoter and
gene activities in HEK293 cells with the presence or
absence of hallmarks of TSSs and of key regulatory
elements. An overview of the diﬀerent features analyzed
for the HSA21 promoters is summarized in Figure 2.
Active promoters are enriched for RNA Pol IIA-bound
regions and activating core promoter elements
To correlate promoter activity with the presence of func-
tional TSSs, we relied on ChIP-seq data that we previously
reported for hypophosphorylated RNA polymerase II
polypeptide A (Pol IIA) used as a landmark of transcrip-
tion initiation in HEK293 cells (16). A large fraction of
active promoter fragments (35 out of 56) contained or
overlapped Pol IIA-bound regions (Figures 2 and 3A),
whereas inactive promoter fragments were strongly
depleted of Pol IIA (12 of 126; Supplementary Table
S1). The enrichment of Pol IIA occupancy in active pro-
moters was highly signiﬁcant (P=2.9 10
 13).
Core promoters are known to be associated with
promoter-speciﬁc sequence elements controlling the initi-
ation of transcription of downstream genes. For instance,
CpG islands, the TATA box, initiator (INR) and down-
stream promoter elements (DPE) are functionally import-
ant, although their presence is not always required for
Figure 1. Active promoters can be reliably distinguished from inactive
promoters using reporter gene assays on transfected-cell arrays.
Promoter reporter activities strongly correlate with endogenous
HEK293 gene expression levels and with breadth of expression accord-
ing to EST data. (A) A promoter was scored active if a cell number
threshold for reporter activity (3 SD over the mean of the negative
controls) and a co-transfection threshold for the two plasmids (16%)
were both exceeded (see ‘Materials and methods’ section for details). A
plot of the mean numbers and standard deviations of co-transfected
cells with reporter activity shows the signiﬁcant diﬀerences between
active and inactive promoter fragments. (B) Active promoter fragments
are mostly derived from genes with endogenous expression in HEK293,
as detected by RNA-seq (16). In contrast, most inactive promoters
correspond to genes without expression in HEK293. (C) The majority
of inactive promoters is derived from genes with restricted expression
patterns, whereas most active promoters correspond to genes with
broader expression patterns (ESTs found in >25 tissues). For each
gene, the number of diﬀerent human tissues with corresponding ESTs
according to the UniGene database was determined and plotted against
active and silent promoter fractions.
Nucleic Acids Research, 2010,Vol.38, No. 18 6115promoter activity (7,8,28). We analyzed the occurrence of
these four elements within the 500bp near the TSSs of all
182 cloned promoter fragments (Supplementary Table
S1). Based on a genome-wide reference map of CpG
islands (21), we observed that 83 of the 182 cloned pro-
moters (46%) overlapped with a CpG island over a
sequence length of at least 50bp, and that these islands
were almost always located at the TSS (98% of the cases).
Active promoters were highly enriched for CpG islands
(P=2.3 10
 11) when compared to the silent ones (46
out of 56, and 37 out of 126, respectively). The TATA
box, located 28 to 34bp upstream of the TSS (29), is the
best-known core promoter element. TATA boxes are
often associated with strong tissue-speciﬁc promoters
and result in clearly deﬁned TSSs (8). TATA boxes were
present in only 14 of the 182 cloned promoters (7.7%),
which is slightly below the previously reported portion of
TATA-containing promoters among all known human
promoters, estimated to be from 10 to 20% (30). TATA
boxes occurred almost twice as frequently in silent pro-
moters (9% with TATA) than in active promoters
(5% with TATA), but this enrichment was not signiﬁcant.
No trend was observed for the INR element, which was
present in 7% of the active fragments (4 of 56) and in
6% of inactive promoters (8 of 126). On the other hand,
as shown in Figure 3A, a DPE element was found in half
of the active promoters (28 of 56) but in only in one-third
of silent promoters (42 of 126; P=0.025; Figure 3A).
Three elements occurred together in a signiﬁcant number
of cases. Of the 47 promoters with Pol IIA occupancy,
45 contained a CpG island and 24 a DPE element.
Lastly, it is notable that 53 inactive fragments did not
overlap with any of the promoter elements or Pol
IIA-bound regions.
External stimuli modulate the activities of diﬀerent sets of
promoters
To assess further the functionality of the cloned promoter
fragments, we monitored promoter activities after
Figure 2. Overview of promoter reporter activities, gene expression
data and core promoter elements for 182 tested 2.5kb promoters.
Each row in the panels represents one tested promoter, with gene
symbols indicated on the left. The panel on the left shows promoter
reporter gene activities for untreated HEK293 cells measured on
transfected-cell arrays, corresponding endogenous gene expression
(RNA-seq) and RNA polymerase IIA occupancy (Pol IIA). The
central panel shows promoter reporter activities after treatment on
transfected-cell arrays with Trichostatin A (+TSA) and after depletion
of fetal calf serum (-FCS). The panel on the right shows the presence or
absence of core promoter elements residing in the cloned fragments.
Promoter reporter activity: active promoters driving reporter gene ex-
pression are represented by green boxes, inactive promoters by red
boxes. RNA-seq: transcriptome sequencing data from HEK293 cells
(16); green—transcripts detected in HEK293; red—no transcripts
detected or uncertain; Pol IIA: Blue boxes indicate RNA Polymerase
IIA-bound regions in promoters identiﬁed by chromatin immunopre-
cipitation (ChIP-seq) from HEK293 cells (16). Promoter elements:
Light gray boxes indicate the presence of CpG islands, downstream
promoter elements (DPE), TATA boxes and initiator elements (INR).
EST data: The number of diﬀerent tissues (out of 45) in which corres-
ponding ESTs are present in the UniGene database is represented here
as the length of a horizontal bar. All rows are sorted (i) by promoter
reporter activity in untreated conditions, (ii) by endogenous expres-
sion in HEK293 cells, and (iii) by promoter activities in treated
conditions.
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(TSA) or by depletion of fetal calf serum (FCS) from
the culture medium. The eﬀects of TSA (an inhibitor
of class I and II histone deacetylases) on cell function
are complex and include triggering the activation of
transcription from repressed regions of the chromosomes
(31). Here, TSA treatment activated 28 of the 126 inactive
promoters, whereas only three of the 56 previously active
promoters were silenced (Figure 2). The genes activated by
TSA did not belong to any speciﬁc category of biological
function (data not shown). A large fraction of the
TSA-activated genes (15/28) exhibited a broad expression
proﬁle (ESTs in >25 tissues), in contrast to those which
remained silent (14/98; P=5 10
 5, see Figure 3B).
Similarly, we observed signiﬁcant enrichments of
endogenously expressed genes and Pol IIA binding
regions (Figure 3B). Interestingly, CpG islands repre-
sented the most frequently observed class of elements,
found present in 68% of TSA-activated promoters
(Figure 3B), whereas no enrichment for either TATA,
INR or DPE elements was detected.
Serum depletion from the cell culture medium is known
to elicit stress responses and apoptosis through activation
of several factors, such as NF B and CREB (32–34). Here,
after the cells were deprived of serum for 24h, no
promoter was silenced. However, 40 promoters were
activated, of which 19 were also found to be activated
by TSA (Figure 2). Comparison of the speciﬁc features
of promoters activated by TSA or serum depletion
(Figure 3B and C) showed, in both cases, enrichment of
genes with broad expression patterns and with CpG
islands, albeit the latter feature was more pronounced
among promoters responding to TSA. However, in
contrast to the TSA treatment, promoters activated by
serum depletion were not enriched for genes endogenously
expressed in HEK293 cells or marked by RNA Pol IIA
occupancy. Instead, a signiﬁcant enrichment of DPE
elements was observed. CpG islands and DPE elements
occurred together in 28% of promoters activated by
serum depletion (11/40), but only in 8% of promoters
that remained silent (7/86). We found that 20% of the
activated promoters corresponded to genes asso-
ciated with cellular responses to the environment
(Supplementary Table S1). In contrast, only 8%
of the promoters remaining inactive belonged to this
category.
Altogether, monitoring HSA21 promoter gene activity
on transfected-cell arrays revealed that 56/182 promoters
of 2500bp in length were able to drive reporter gene ex-
pression in HEK293 cells under normal growth condi-
tions. Assays in the presence of diﬀerent external stimuli
showed that an additional 49 promoter fragments have the
capacity to induce reporter gene expression. Figure 4
shows the associated EST data from 45 diﬀerent tissues
and gene expression levels in HEK293 cells. Those pro-
moters that were active under standard conditions were
expressed in a large number of tissues and exhibited rela-
tively high endogenous expression levels in HEK293 cells.
The set of promoters that could be activated by TSA ex-
hibited slightly lower expression levels in both data sets,
while the promoters activated through serum depletion
tend to be expressed in signiﬁcantly fewer tissues and
showed only weak expression in HEK293 cells. For the
77 silent fragments that could not be activated, only sparse
EST data were available, and only 17 promoters were
associated with genes expressed in HEK293 cells. A
closer inspection of these 17 inactive fragments, together
with integration of Pol IIA ChIP-seq and RNA-seq data,
revealed that in four cases the core promoter was missed
by 10–30bp (for C21orf19, C21orf90, HEMK2 and
PFKL), and that in ﬁve cases an alternative TSS was
used for these genes in HEK293 cells (ABCG1, MRPS6,
NCAM2, NRIP1 and PCBP3). Apart from these cases,
the majority of cloned HSA21 promoters recapitulated
their function in living cells.
Figure 3. Gene expression features and sequence elements associated
with active and silent promoter fragments. (A) The 56 promoters
active under untreated conditions are signiﬁcantly enriched for genes
with expression in >25 diﬀerent tissues (broadly expressed), for genes
endogenously expressed in HEK293 cells (HEK expressed), for occu-
pancy of RNA polymerase IIA in the promoter fragment (Pol IIA
binding), for presence of CpG islands and for downstream promoter
elements (DPE). Dark grey bars represent the fraction of 56 active
promoters associated with the indicated feature; light grey bars repre-
sent the fraction of 126 promoters inactive in untreated conditions.
(B) Treatment of cells with Trichostatin A activates 28 promoters
that are signiﬁcantly enriched for broadly expressed genes, expression
in HEK293, Pol IIA binding and CpG islands. (C) Depletion of serum
from transfected cells activates 40 promoters that are signiﬁcantly
enriched for broadly expressed genes, CpG islands and DPE
elements. Signiﬁcance levels of enrichments were calculated by the
hypergeometric test and are indicated as ***P<0.001, **P<0.01,
*P<0.05 and ns: not signiﬁcant.
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regulatory elements
To investigate the inﬂuence of distal promoter regions on
transcription, we cloned a subset of 62 truncated promoter
fragments of  500bp, thus removing the distal  2000
bases. Under standard conditions, 29 of the 62 short frag-
ments could drive transcription in reporter assays (Figure
5). Compared to assays performed with the long frag-
ments, truncation of promoter length resulted in loss of
activity for only three cases (DSCR2, OLIG1 and SIM2).
However, six promoters gained activity in their truncated
form, while their longer version was inactive (MRPL39,
RBM11, CHAF1B, HLCS, C21orf45 and SH3BGR), sug-
gesting the presence of inhibitory regulatory regions in the
distal  2000bp sequences.
Regarding the responses of short fragments to treat-
ments with TSA and depletion of serum, we found
that 40 short promoters (66%) recapitulate, under all
conditions, the activity patterns observed for the long
fragments (Figure 5, lower part), while the remaining
21 behaved diﬀerently (Figure 5, upper part). In contrast
to their longer counterpart, 14 truncated promoters
could not be activated by any treatment, indicating the
loss of activating cis-regulatory upstream elements.
Conversely, seven truncated promoters could be activated
under more conditions than their longer counterparts
(C21orf66, C21orf45, CHAF1B, MRPL39, HLCS,
RBM11 and SH3BGR), suggesting that they have lost
inhibitory elements located in the distal  2000bp
sequences.
Figure 5. Truncation of promoter fragments can result in loss of re-
sponsiveness to external stimuli. The panels show an overview of
reporter activities of 62 promoters that were assayed as both long
(2.5kb) and truncated fragments ( 500bp). Each row represents one
tested pair of long and short promoter, with gene symbols indicated on
the left. Active promoters are represented by dark grey boxes, inactive
promoters by light grey boxes. Reporter assays were carried out under
standard growth conditions (untreated), after treatment of cells with
Trichostatin A (+TSA) and after depletion of fetal calf serum (-FCS).
Promoters are sorted by the result of truncation, which is either loss of
response to external stimuli (21 promoters, upper part) or no change in
the response to stimuli (41 promoters, lower part). The presence of
upstream cis-regulatory elements in distal promoter regions (–2500 to
–500bp) can be inferred from the observed results of truncation,
namely activating upstream elements (14 promoters) or inhibitory
elements (seven promoters).
Figure 4. Promoter activities and responses to external stimuli are
correlated with endogenous gene expression levels. The distributions
of expression values are represented by box-and-whiskers plots for
the promoters active in untreated cells (n=56), for the promoters
activated by TSA treatment (n=28) or by depletion of serum
(n=40) and for the promoters that stay inactive under all tested con-
ditions (n=77). (A) Distributions of the numbers of tissues with ex-
pression according to UniGene EST data. (B) Box-and-whiskers plot
showing the distribution of normalized expression values in HEK293
according to RNA-seq data (16). Boxes in the plots stretch from the
25th percentile to the 75th percentile of the distribution (inter-quartile
range). The median number of tissues is shown as a line across the box.
The whiskers stretch to the minimum and maximum data values, unless
outliers are present, in which case the whiskers extend to a maximum of
1.5 times the inter-quartile range. Outliers located beyond the whiskers
are shown as circles.
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promoters responding to external stimuli
We aimed to identify cis-regulatory elements that might
contribute to the response patterns observed after treat-
ment with external stimuli. We ranked aﬃnities for 610
known vertebrate transcription factor (TF) binding
matrices (20) for the 2.5kb promoters activated by
serum depletion or TSA treatment, and for the distal
2000bp region of promoters which had lost their
capacity to be activated by either of those stimuli upon
truncation (see ‘Materials and methods’ section). Of the
TF binding matrices enriched in the sequences from each
class of promoter, we retained only data pertaining to TFs
expressed in HEK293 cells. We found that the highest
ranked factors tend to be related to serum responses or
TSA treatment (Table 1). All binding sites detected for
these TFs in the analyzed promoter fragments are listed
in Supplementary Table S1. Results are in accordance
with previous reports that demonstrated the importance
of USF1, NF B, MYC and ETS1 activities in serum
response. For the TSA responses and associated histone
deacetylase inhibition, we found reports describing re-
sponses to TSA treatment for MAFG, AP1 (FOS/JUN),
p53 and OCT1. Thus, four of seven TFs with enriched
binding sites in serum-sensitive promoters and four of
eight TFs with enriched sites in TSA-responsive promoters
have been previously implicated in corresponding signal
transduction pathways.
DISCUSSION
Using a transfected-cell array procedure, we monitored
the activities of 182 cloned promoters corresponding to
 80% of all HSA21 genes in HEK293 cells. Compared
to previous studies, where the length of promoters was no
larger than 1000bp (6,35,36), we aimed here at a more
comprehensive coverage of potential upstream regulatory
elements by cloning 2500bp fragments. In addition, we
challenged the cells with external stimuli to identify the
regulatory nature of the elements in the cloned promoters.
In this, the cell array format proved reliable and represents
a cost-eﬃcient alternative to conventional reporter gene
assays in microtiter plates.
Correlations between promoter reporter activities and
endogenous expression
Our data showed that promoter reporter activities
recapitulated endogenous gene expression to a great
extent (89% concordance). Nevertheless, no transcripts
were detected for six genes whose promoters were active
on the cell arrays (C21orf13, C21orf115, DSCR4, DSCR8,
KRTAP21-2 and RSPH1). Four of these genes are ex-
pressed in only a few tissues according to EST data. The
activity of these promoters in our assay might indicate
that elements repressing the expression of those genes in
HEK293 were not included in the promoter reporter con-
structs, or that tight chromatin structures or DNA methy-
lation occurring in the natural genomic context were not
recapitulated in the reporter constructs. Conversely, for 37
out of 126 promoters inactive under standard conditions,
we found expression of the corresponding genes in
HEK293 cells. In fact, the majority of these promoters
were activated by treatment with TSA or serum depletion,
suggesting that the corresponding cloned fragments con-
tained a functional core promoter but lacked binding sites
for activating factors essential to lift reporter gene expres-
sion above the detection threshold. The larger part of the
remaining 17 inactive promoters missed the core promoter
required for transcription; either due to inadequate TSS
annotation or use of an alternative TSS in HEK293 cells
Table 1. Top-enriched transcription factor binding matrices among promoters responding to external stimuli
Promoter response category
(no. of promoters; analyzed regions)
Enriched TF
binding matrix
Combined
P-value
Promoters
with motif
Transcription
factor
References to
stimulus
Activation by serum depletion V$USF_C 0.000104 48% USF1 (54)
(n=40; full 2.5kb regions) V$OSF2_Q6 0.000155 80% RUNX2 –
V$NFKAPPAB_01 0.00279 85% NF B (32)
V$MYC_Q2 0.00355 48% MYC (56,63)
Loss of activation by serum depletion V$NFKAPPAB_01 0.00287 89% NF B (32)
after truncation to 500bp V$NERF_Q2 0.007 78% ELF2 –
(n=9; 2kb distal regions) V$ETS1_B 0.00938 100% ETS1 (55)
V$MAF_Q6 0.00979 89% MAF –
Activation by Trichostatin A V$POU3F2_01 0.00127 86% OCT7 –
(n=28; full 2.5kb regions) V$TCF11MAFG_01 0.00355 93% MAFG (57)
V$AP1_Q2 0.00372 71% AP1 (61)
V$MEF2_01 0.00432 86% MYEF2 –
Loss of activation by Trichostatin A V$P53_01 0.015 50% p53 (58,59)
after truncation to 500bp V$OCT1_01 0.0258 67% OCT1 (60)
(n=6; 2kb distal regions) V$MAF_Q6 0.0345 83% MAF –
V$TEF1_Q6 0.0396 83% TEAD1 –
Aﬃnities for 610 known vertebrate TF-binding matrices (20) were ranked in the entire sequences of the promoters activated by serum depletion or
TSA treatment, and in the distal 2000bp of those promoters that lost their activation by stimuli after these regions had been removed by truncation.
The P-values in each set were combined using Fisher’s method and represent the probability that the observed binding aﬃnities are obtained
by chance from a random set of sequences from a human-promoter-based background model. The table also lists references describing known
connections between the identiﬁed TFs and the applied stimuli. All identiﬁed binding motifs in the analyzed promoter regions are listed in
Supplementary Table S1.
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in HEK293 and other cultured cells will beneﬁt from the
wealth of data that is now becoming available from
RNA-seq and TSS-seq (37). The TSA-activated promoters
generally exhibited broader expression patterns and higher
expression levels in HEK293 cells than the promoters
activated after serum depletion, suggesting that TSA
enhanced the activity of promoters that were already
active at low levels, while serum depletion leads to activa-
tion of previously inactive promoters.
We observed that the co-occurrence of core promoter
elements and Pol IIA occupancy were hallmarks of
promoter activity. The ﬁnding of signiﬁcant enrichments
of CpG islands and DPE elements, but not TATA or INR
elements in active promoters conﬁrmed previous observa-
tions (35,38). CpG islands are present within more than
80% of the promoters active in HEK293 cells, a feature
previously reported in other cell types, such as primary
ﬁbroblasts (39). Moreover, the strong correlation
between gene expression levels and promoter activity in
our reporter assays concerned mostly genes containing
CpG islands. RNA polymerase IIA-binding could either
correspond to Pol II stalling at genes poised for activation
(40,41), where CpG islands are also known to be enriched
(42), or to active TSSs (16,43). As expected, we found the
presence of Pol IIA-bound regions strongly associated
with active promoter fragments.
Inﬂuences of chromatin states and CpG methylation on
promoter reporter activity
We observed that a subset of the silent promoters was
activated by treatment with Trichostatin A. An expected
eﬀect of TSA, a speciﬁc inhibitor of mammalian class I and
II histone deacetylase enzymes (31), is the activation of
transcription from repressed chromosomal regions
through chromatin remodeling (44). Transiently trans-
fected plasmids are not entirely subjected to the same regu-
latory mechanisms that aﬀect native chromatin, but it has
been shown that chromatin structures can be formed on
plasmid DNA (45). Subsequently, it should be possible to
reverse histone deacetylase-dependent silencing mechan-
isms by TSA (46,47). Indeed, TSA was able to activate 28
of the silent cloned promoters. Apart from the eﬀects of
TSA on histone acetylation, it might also be possible that
TSA has an indirect inﬂuence on CpG methylation. We
found that 68% of the TSA-activated promoters contain
a CpG island. It has been shown that in some cell lines,
TSA downregulates the expression of the DNA methyl-
transferase DNMT1 (48), and that CpG demethylation
occurs at genes with low expression levels, which are then
fully activated upon demethylation (49). Taken together, it
is likely that the promoter-reporter constructs are sensible
to histone deacetylation, or to DNA methylation-mediated
silencing (50,51), or to both mechanisms.
Cis-regulatory elements involved in cellular responses to
TSA and serum depletion
The comparison of the activities of long and short
promoter fragments showed that only three promoters
lost their activity upon truncation. This ﬁnding implies
that in general, proximal promoter regions are suﬃcient
to drive gene expression. A diﬀerent picture emerges when
activity changes through external stimuli are taken into
account. Here, 29% of all tested long fragments changed
their activity upon stimulation by TSA or serum deple-
tion, while only 5% of the tested short fragments re-
sponded to these stimuli. The observed diﬀerence is
evidence for the presence of cis-regulatory response
elements in the distal promoter regions of these genes.
Depletion of serum triggers cell type-speciﬁc responses
aﬀecting cell cycle regulation, cell growth, diﬀerentiation
and apoptosis (33,52,53). Indeed, among the 40 promoters
activated by serum depletion, one-ﬁfth was annotated
within the GO category ‘response to stimulus’. Analysis
of TFBSs in the promoters of the genes activated by serum
depletion showed strong enrichment of binding sites for
seven transcription factors. Notably, four of the
top-ranking factors (USF1, NF B, ETS1 and MYC)
have already been shown to be involved in responses to
serum starvation. For instance, this treatment enhanced
USF1 expression and binding of USF1 in the promoter of
the target gene lipocalin-type PGD synthase in
brain-derived cells (54). NF B has been found potently
activated upon serum starvation in HEK293 cells,
leading to apoptosis (32). Ets domain-containing tran-
scription factors, such as ETS1 identiﬁed here, are
implicated in the response to serum in endothelial cells
(55). Finally, MYC has been previously implied in re-
sponses to growth factor-deprived conditions, where it is
involved in induction of apoptosis (56).
Analysis of TFBSs in the promoters of the genes
activated by TSA showed strong enrichment of binding
sites for eight transcription factors. Remarkably, similar
to serum depletion, four of these factors (MAFG, p53,
OCT1 and AP1) have previously been shown to be respon-
sive to TSA treatment. TSA can abolish MAFG-mediated
repression of gene expression via Maf recognition
elements in reporter gene assays in HEK293 cells (57),
leading to gene activation. TSA can induce p53-mediated
cell cycle arrest or apoptosis, depending on the cell type
(58,59). TSA can also induce gene expression via OCT1,
independently of p53 (60). In addition, TSA can promote
the binding of AP1 to a recognition site and activate the
expression of the osteoporin gene in a mouse mesenchy-
mal cell line (61). The activating eﬀects of TSA, originally
shown for speciﬁc genes as reported above, seem to rep-
resent a more general mechanism targeting the genes
whose promoters contain binding sites for these transcrip-
tion factors.
We observed similarities in the responses of promoters
to serum depletion with that to TSA treatment, given that
19 promoters were activated by both types of treatment in
our reporter assays. One explanation for this overlap
might involve the TSA-responsive AP1 complex, which
is composed of members of the JUN, FOS and CREB/
ATF families. JUN is also a mediator of the MYC-
induced apoptotic signaling following serum starvation
(56). Thus, JUN is involved in mediating the responses
to both TSA treatment and serum depletion, which
might explain the observed overlap between the sets of
promoters activated by these stimuli.
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Using reporter gene assays on transfected-cell arrays, we
showed that cloned promoter fragments largely recapitu-
late gene expression driven by the endogenous promoters,
with integration of endogenous signaling pathways into
reporter gene expression. Under standard conditions,
cloned promoters of  500bp in size, spanning core and
proximal promoter regions, are generally suﬃcient to
drive gene expression. Comparative analysis of the
activities of long and short promoters highlighted the
presence of inhibitory cis-regulatory elements within
 500 to  2500bp for six promoters. Extended promoter
regions were found necessary in many cases to integrate
cellular signaling into reporter gene expression. Upon
truncation, a signiﬁcant number of promoters lost their
response to cellular signaling. Monitoring the activity of
long and short promoter fragments upon stimulation
showed evidence for both inhibitory and activating
response elements upstream of the 500bp proximal
promoter. Although it has been reported that promoter
truncation reveals predominantly the presence of negative
regulatory elements within 1000 to 500bp upstream of the
TSS (35,62), we found here that activating distal promoter
elements were signiﬁcantly more frequent than negative
elements in our experimental set-up.
This chromosome-scale promoter study sheds some
light upon both general and speciﬁc regulatory response
elements controlling gene activity. The identiﬁed promoter
activities and responses to stimuli constitute a valuable
resource for further investigations. This collection of
cloned HSA21 promoters could be used in future
promoter activity studies in diﬀerent cell lines, or in com-
bination with transcription factor overexpression or
knock-down, thereby allowing researchers to build a
detailed understanding of the mechanisms of transcrip-
tional regulation across an entire chromosome.
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